$640M Question: 'What Did McKinsey Get' In Big Opioid Deal?

By Jeff Overley · March 31, 2022, 10:43 PM EDT

A California federal judge indicated Thursday that sprawling litigation targeting McKinsey & Co.'s opioid marketing advice will soon see its fate decided by a single thorny question: Were the legal grievances...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In re: McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation

Case Number

3:21-md-02996

Court

California Northern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

June 08, 2021